MC1423A1 - Production microbienne d'interferon de fibroplaste humain - Google Patents

Production microbienne d'interferon de fibroplaste humain

Info

Publication number
MC1423A1
MC1423A1 MC811542A MC1542A MC1423A1 MC 1423 A1 MC1423 A1 MC 1423A1 MC 811542 A MC811542 A MC 811542A MC 1542 A MC1542 A MC 1542A MC 1423 A1 MC1423 A1 MC 1423A1
Authority
MC
Monaco
Prior art keywords
amino acid
polypeptide
interferon
presequence
sequence
Prior art date
Application number
MC811542A
Other languages
English (en)
French (fr)
Inventor
Roberto Crea
Goeddel David Van Norman
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26886463&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MC1423(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MC1423A1 publication Critical patent/MC1423A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/565IFN-beta
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
MC811542A 1980-09-25 1981-09-24 Production microbienne d'interferon de fibroplaste humain MC1423A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19079980A 1980-09-25 1980-09-25
US29189281A 1981-08-11 1981-08-11

Publications (1)

Publication Number Publication Date
MC1423A1 true MC1423A1 (fr) 1982-10-18

Family

ID=26886463

Family Applications (1)

Application Number Title Priority Date Filing Date
MC811542A MC1423A1 (fr) 1980-09-25 1981-09-24 Production microbienne d'interferon de fibroplaste humain

Country Status (33)

Country Link
US (1) US5460811A (OSRAM)
EP (1) EP0048970A3 (OSRAM)
AT (1) AT380694B (OSRAM)
AU (1) AU582110B2 (OSRAM)
BR (1) BR8106137A (OSRAM)
CA (1) CA1341569C (OSRAM)
CH (2) CH656388A5 (OSRAM)
DD (3) DD202085A5 (OSRAM)
DE (1) DE3138096A1 (OSRAM)
DK (1) DK423381A (OSRAM)
ES (3) ES8307297A1 (OSRAM)
FI (1) FI812993L (OSRAM)
FR (1) FR2490675B1 (OSRAM)
GB (1) GB2098996B (OSRAM)
GR (1) GR81946B (OSRAM)
HK (1) HK43686A (OSRAM)
IE (1) IE51679B1 (OSRAM)
IL (1) IL63916A0 (OSRAM)
IT (1) IT1139487B (OSRAM)
KE (1) KE3630A (OSRAM)
LU (1) LU83648A1 (OSRAM)
MC (1) MC1423A1 (OSRAM)
MT (1) MTP900B (OSRAM)
MY (1) MY8600634A (OSRAM)
NL (1) NL8104400A (OSRAM)
NO (1) NO813248L (OSRAM)
NZ (1) NZ198445A (OSRAM)
OA (1) OA06908A (OSRAM)
PL (1) PL233194A1 (OSRAM)
PT (1) PT73728B (OSRAM)
SE (1) SE8105657L (OSRAM)
YU (1) YU44835B (OSRAM)
ZW (1) ZW23981A1 (OSRAM)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK33181A (da) * 1980-02-06 1981-08-07 Searle & Co Fremgangsmaade til fremstilling af et interferonlignende protein
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
NO811118L (no) 1980-04-03 1981-10-05 Biogen Nv Dna-sekvenser, rekombinante dna-molekyler og fremgangsmaate ved fremstilling av polypeptider
ATE25985T1 (de) * 1980-06-12 1987-04-15 Japan Found Cancer Plasmid.
DK489481A (da) * 1980-11-10 1982-05-11 Searle & Co Plasmidvektor og frmgangsmaade til fremstilling deraf
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
JPS58110600A (ja) * 1981-12-25 1983-07-01 Kyowa Hakko Kogyo Co Ltd ヒトβ型インタ−フエロン遺伝子を含む組みかえ体プラスミド
IE54592B1 (en) * 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
US6432677B1 (en) 1982-03-08 2002-08-13 Genentech, Inc. Non-human animal interferons
US4775622A (en) * 1982-03-08 1988-10-04 Genentech, Inc. Expression, processing and secretion of heterologous protein by yeast
US5827694A (en) * 1982-03-08 1998-10-27 Genentech, Inc. DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides
EP0121569B1 (en) * 1982-10-08 1990-08-22 Kyowa Hakko Kogyo Co., Ltd. Novel vector
US5831023A (en) * 1982-11-01 1998-11-03 Genentech, Inc. Recombinant animal interferon polypeptides
GR79124B (OSRAM) * 1982-12-22 1984-10-02 Genentech Inc
US4512922A (en) * 1982-12-22 1985-04-23 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4518526A (en) * 1982-12-22 1985-05-21 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4599197A (en) * 1982-12-22 1986-07-08 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4620948A (en) * 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511502A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US5683688A (en) * 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
GB8414354D0 (en) * 1984-06-05 1984-07-11 Biogen Nv Purifying protein
US5231176A (en) * 1984-08-27 1993-07-27 Genentech, Inc. Distinct family DNA encoding of human leukocyte interferons
DE3574145D1 (en) * 1984-08-27 1989-12-14 Genentech Inc Novel, distinct family of human leukocyte interferons, compositions containing them, methods for their production, and dna and transfected hosts therefor
US4680262A (en) * 1984-10-05 1987-07-14 Genentech, Inc. Periplasmic protein recovery
US5618920A (en) 1985-11-01 1997-04-08 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
EP0237019A3 (en) * 1986-03-14 1988-03-09 Toray Industries, Inc. Interferon conjugate and production thereof using recombinant gene
GB9022543D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Antibody production
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
US20050002902A1 (en) * 1995-12-28 2005-01-06 Liming Yu Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections
US20030026779A1 (en) * 1999-10-15 2003-02-06 Liming Yu Treatment of tumors and viral infections with a hybrid conjugate of interferon and an immunoglobulin Fc
US6713609B1 (en) * 1996-07-16 2004-03-30 Genentech, Inc. Monoclonal antibodies to type I interferon receptor
JP3576819B2 (ja) 1997-07-30 2004-10-13 キヤノン株式会社 情報処理装置及び印刷制御方法並びに記憶媒体
US20030018174A1 (en) * 1997-10-06 2003-01-23 Genentech, Inc. Monoclonal antibodies to IFNAR2
WO2000056924A2 (en) 1999-03-24 2000-09-28 Genset Genomic sequence of the purh gene and purh-related biallelic markers
AU2001261024A1 (en) 2000-04-12 2001-10-30 Delta Biotechnology Limited Albumin fusion proteins
AU2002246955B2 (en) * 2001-01-09 2007-03-22 Baylor Research Institute Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
EP2277910A1 (en) 2001-12-21 2011-01-26 Human Genome Sciences, Inc. Albumin fusion proteins
KR101271635B1 (ko) * 2001-12-21 2013-06-12 휴먼 게놈 사이언시즈, 인코포레이티드 알부민 융합 단백질
MXPA05006944A (es) 2002-12-26 2005-12-14 Mountain View Pharmaceuticals Conjugados polimericos de interferon-beta cion potencia biologica aumentada.
JP2006519170A (ja) * 2002-12-26 2006-08-24 マウンテン ビュー ファーマシューティカルズ,インコーポレイテッド サイトカイン、ケモカイン、増殖因子、ポリペプチドホルモン、およびレセプター結合活性が保存されたそのアンタゴニストのポリマー結合体
EP1594530A4 (en) 2003-01-22 2006-10-11 Human Genome Sciences Inc HYBRID PROTEINS OF ALBUMIN
NZ548255A (en) 2004-02-02 2010-10-29 Ambrx Inc Modified human interferon polypeptides and their uses
AU2009212311B8 (en) 2004-07-21 2013-05-30 Ambrx, Inc. Modified leptin polypeptides and their uses
US20070081995A1 (en) * 2005-06-22 2007-04-12 Genentech, Inc. Methods and compositions for targeting IFNAR2

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG38165A3 (bg) * 1977-11-08 1985-10-15 Genentech, Inc. Метод за получаване на рекомбинантен клониращ вектор,подходящ за трансформиране на микробен приемник
US4411994A (en) * 1978-06-08 1983-10-25 The President And Fellows Of Harvard College Protein synthesis
IN150740B (OSRAM) * 1978-11-24 1982-12-04 Hoffmann La Roche
US4332892A (en) * 1979-01-15 1982-06-01 President And Fellows Of Harvard College Protein synthesis
US4262090A (en) * 1979-06-04 1981-04-14 Cetus Corporation Interferon production
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
US4289689A (en) * 1980-03-14 1981-09-15 Hoffmann-La Roche Inc. Preparation of homogeneous human fibroblast interferon
CH648331A5 (de) * 1979-07-31 1985-03-15 Hoffmann La Roche Homogenes fibroblasten-interferon und dessen herstellung.
AU538665B2 (en) * 1979-10-30 1984-08-23 Juridical Foundation, Japanese Foundation For Cancer Research Human interferon dna
IL58765A (en) * 1979-11-21 1986-09-30 Yeda Res & Dev Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta
US4418149A (en) * 1980-01-10 1983-11-29 President And Fellows Of Harvard College Fused hybrid gene
GB2068970B (en) * 1980-02-06 1983-06-22 Searle & Co Recombinant dna technique for the preparation of a protein resembling human interferon
DK33181A (da) * 1980-02-06 1981-08-07 Searle & Co Fremgangsmaade til fremstilling af et interferonlignende protein
DE3005843A1 (de) * 1980-02-16 1981-09-10 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
NO811118L (no) * 1980-04-03 1981-10-05 Biogen Nv Dna-sekvenser, rekombinante dna-molekyler og fremgangsmaate ved fremstilling av polypeptider
ATE25985T1 (de) * 1980-06-12 1987-04-15 Japan Found Cancer Plasmid.
US4874702A (en) * 1980-09-08 1989-10-17 Biogen, Inc. Vectors and methods for making such vectors and for expressive cloned genes

Also Published As

Publication number Publication date
ES515033A0 (es) 1983-06-01
FI812993A7 (fi) 1982-03-26
BR8106137A (pt) 1982-06-15
ZW23981A1 (en) 1982-04-28
EP0048970A3 (en) 1982-08-18
LU83648A1 (de) 1983-06-08
ES505742A0 (es) 1983-07-01
DD202085A5 (de) 1983-08-24
MY8600634A (en) 1986-12-31
PT73728A (en) 1981-10-01
KE3630A (en) 1986-05-16
PT73728B (en) 1984-05-08
GB2098996B (en) 1985-02-06
AT380694B (de) 1986-06-25
PL233194A1 (en) 1983-07-18
YU44835B (en) 1991-04-30
EP0048970A2 (en) 1982-04-07
ES8306325A1 (es) 1983-06-01
SE8105657L (sv) 1982-03-26
US5460811A (en) 1995-10-24
DD209477A5 (de) 1984-05-09
IE812224L (en) 1982-03-25
AU7564981A (en) 1982-04-01
CA1341569C (en) 2008-03-25
HK43686A (en) 1986-06-20
IT8124109A0 (it) 1981-09-23
DK423381A (da) 1982-03-26
FI812993L (fi) 1982-03-26
DE3138096A1 (de) 1982-06-09
CH651309A5 (de) 1985-09-13
AU582110B2 (en) 1989-03-16
GR81946B (OSRAM) 1984-12-12
IL63916A0 (en) 1981-12-31
FR2490675B1 (fr) 1985-11-15
NO813248L (no) 1982-03-26
IE51679B1 (en) 1987-02-04
ES515032A0 (es) 1983-06-01
ES8307297A1 (es) 1983-07-01
GB2098996A (en) 1982-12-01
YU229781A (en) 1984-02-29
CH656388A5 (de) 1986-06-30
NL8104400A (nl) 1982-04-16
ES8306324A1 (es) 1983-06-01
FR2490675A1 (fr) 1982-03-26
DD209652A5 (de) 1984-05-16
OA06908A (fr) 1983-05-31
MTP900B (en) 1985-02-28
ATA410381A (de) 1985-11-15
NZ198445A (en) 1984-05-31
IT1139487B (it) 1986-09-24

Similar Documents

Publication Publication Date Title
MC1423A1 (fr) Production microbienne d'interferon de fibroplaste humain
MC1396A1 (fr) Interferons et procede pour leur preparation
FI79550B (fi) Foerfarande foer framstaellning av ett humant hybridleukocytinterferon.
US4456748A (en) Hybrid human leukocyte interferons
EP0506574B1 (fr) Protéine à activité de type cytokine, ADN recombinant codant pour cette protéine, cellules et microorganismes transformés
FR2514783A1 (fr) Interferon immunitaire humain
FR2480781A1 (fr) Expression de polypeptide bacterien dans laquelle on emploie un promoteur/operateur de tryptophanne
BE898016A (fr) Muteines appauvries en cysteine provenant de proteines biologiquement actives.
CZ284774B6 (cs) Způsob enzymatického štěpení složených bílkovin
SK278336B6 (en) Dna sequences, recombinant dna molecules and processes for producing swing growth hormone-like polypeptides
FR2530662A1 (fr) Nouveaux interferons animaux, leur procede de production et composition les contenant
EP0268501B1 (fr) Protéines à activité glutathion-S-transférase, séquences d'ADN, anticorps, poxvirus et médicaments pour la prévention de la schistosomose
FR2579222A1 (fr) Sequence d'adn, vecteur, hote transforme et procede pour preparer un facteur de croissance de l'epiderme, et methode pour depiler un animal au moyen de ce facteur
FR2509614A1 (fr) Production d'interferon
FR2481316A1 (fr) Technique a adn de recombinant pour la preparation d'une proteine ressemblant a l'interferon humain
AT394209B (de) Verfahren zur herstellung neuer mikroorganismen zur produktion von hybriden human-leukozyten-interferonen
JP2676341B2 (ja) B細胞分化因子の製造法
FI82714B (fi) Foerfarande foer framstaellning av en transformerad stam av e.coli, som foermaor expressera ett humant moget leukocytinterferon.
JP2632680B2 (ja) ブリ成長ホルモン構造遺伝子増幅プラスミド
KR0184767B1 (ko) 재조합 장어 성장 호르몬의 제조방법 및 이를 함유하는 조성물
FR2479259A1 (fr) Techniques a adn de recombinant
FR2610324A1 (fr) Preparation par voie microbiologique de l'angiogenine humaine et conversion de l'enzyme ainsi obtenue en sa forme active
JPS62238219A (ja) ソマトスタチンの製造法
MC1500A1 (fr) Adn nouveau et son procede de production
CH669394A5 (en) Synthetic protein analogues lacking cysteine residues

Legal Events

Date Code Title Description
YP Annual fee paid